These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1574565)

  • 1. Distribution of CCK binding sites in the human hippocampal formation and their alteration in schizophrenia: a post-mortem autoradiographic study.
    Kerwin R; Robinson P; Stephenson J
    Psychol Med; 1992 Feb; 22(1):37-43. PubMed ID: 1574565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional distribution of cholecystokinin receptors in macaque medial temporal lobe determined by in vitro receptor autoradiography.
    Kritzer MF; Innis RB; Goldman-Rakic PS
    J Comp Neurol; 1988 Oct; 276(2):219-30. PubMed ID: 3220981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics.
    Bachus SE; Hyde TM; Herman MM; Egan MF; Kleinman JE
    J Psychiatr Res; 1997; 31(2):233-56. PubMed ID: 9278188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem.
    Kerwin R; Patel S; Meldrum B
    Neuroscience; 1990; 39(1):25-32. PubMed ID: 1982465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiography.
    Kerwin RW; Beats BC
    Neurosci Lett; 1990 Oct; 118(2):164-8. PubMed ID: 2274265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia.
    Virgo L; Humphries C; Mortimer A; Barnes T; Hirsch S; de Belleroche J
    Biol Psychiatry; 1995 May; 37(10):694-701. PubMed ID: 7640324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin-octapeptide (CCK-8) receptors in the hippocampal region: a comparative in vitro autoradiographic study in the rat, monkey and the postmortem human brain.
    Köhler C; Chan-Palay V
    Neurosci Lett; 1988 Jul; 90(1-2):51-6. PubMed ID: 3412648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution of cholecystokinin receptors in primate cerebral cortex determined by in vitro receptor autoradiography.
    Kritzer MF; Innis RB; Goldman-Rakic PS
    J Comp Neurol; 1987 Sep; 263(3):418-35. PubMed ID: 3667984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the distribution of cholecystokinin receptor binding sites in the human brain: an autoradiographic study.
    Dietl MM; Probst A; Palacios JM
    Synapse; 1987; 1(2):169-83. PubMed ID: 3505367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of cholecystokinin binding sites in canine brain using quantitative autoradiography.
    Morency MA; Quirion R; Nair NP; Mishra RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):291-6. PubMed ID: 1871331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.
    Crook JM; Tomaskovic-Crook E; Copolov DL; Dean B
    Biol Psychiatry; 2000 Sep; 48(5):381-8. PubMed ID: 10978721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia.
    Eastwood SL; Burnet PW; Harrison PJ
    Neuroscience; 1995 May; 66(2):309-19. PubMed ID: 7477874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics.
    Kiuchi Y; Kobayashi T; Takeuchi J; Shimizu H; Ogata H; Toru M
    Eur Arch Psychiatry Neurol Sci; 1989; 239(2):71-8. PubMed ID: 2553417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of [3H]cholecystokinin octapeptide binding sites in the hippocampal region of the rat brain as shown by in vitro receptor autoradiography.
    Köhler C; Hallman H; Radesäter AC
    Neuroscience; 1987 Jun; 21(3):857-67. PubMed ID: 3627438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia.
    Kerwin RW; Murray RM
    Schizophr Res; 1992 Apr; 7(1):1-12. PubMed ID: 1350459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of cholecystokinin receptors in the bovine brain: a quantitative autoradiographic study.
    Morency MA; Quirion R; Mishra RK
    Neuroscience; 1994 Sep; 62(1):307-16. PubMed ID: 7816208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics.
    Joyce JN; Lexow N; Kim SJ; Artymyshyn R; Senzon S; Lawrence D; Cassanova MF; Kleinman JE; Bird ED; Winokur A
    Synapse; 1992 Mar; 10(3):228-46. PubMed ID: 1313605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study.
    Goldsmith SK; Shapiro RM; Joyce JN
    Arch Gen Psychiatry; 1997 Jul; 54(7):649-58. PubMed ID: 9236549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of cholecystokinin receptors in the vertebrate brain: species differences studied by receptor autoradiography.
    Dietl MM; Palacios JM
    J Chem Neuroanat; 1989; 2(3):149-61. PubMed ID: 2789732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hippocampus and parahippocampus in schizophrenia, suicide, and control brains.
    Altshuler LL; Casanova MF; Goldberg TE; Kleinman JE
    Arch Gen Psychiatry; 1990 Nov; 47(11):1029-34. PubMed ID: 2241505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.